JOB STRESS in OPHthalmology Physicians and Residents (JOBSTRESS-OPH)

June 3, 2022 updated by: University Hospital, Clermont-Ferrand

Monitoring of JOB STRESS Related to Night Shifts in OPHthalmology Physicians and Residents

Ophthalmology physicians and residents work under stress conditions during night emergency ophthalmology shifts. Under time pressure, that is a characteristic of the urgency of care, they must use all their cognitive resources to make an accurate diagnosis and to provide accurate decisions, with sometimes surgical emergency acts. In addition, in France, they work at night following by an usual day work, and they can also work 48 consecutive hours during weekends, followed by a work day … i.e. 60 consecutive hours of work … Long working hours with a short recovery time has been demonstrated to be a major factor of stress and fatigue. Even if not demonstrated on ophthalmologists, those working conditions may contribute to symptoms of mental exhaustion and physical fatigue (sleep deprivation), often accompanied by a loss of motivation at work. This may leads to a feeling of loss of time control; stress can also distort the perception of time and leads to hasty actions or delayed decision-making. The combined effects of stress, feelings of loss of time control, and fatigue necessarily have an impact on work performance and work quality, with a high risk of medical error. Moreover, prolonged stress may expose ophthalmologists to a higher risk of multiple diseases, predominantly systemic inflammation and coronary heart disease.

The main hypothesis is that prolonged work (up to 60 consecutive working hours) may impact on HRV, comparatively to a typical working day.

Study Overview

Status

Recruiting

Detailed Description

The JOBSTRESS.OPH protocol was designed to study the impact of prolonged work (up to 60 consecutive working hours) on HRV, comparatively to a typical working day. Each residents and / or ophthalmology physicians participates up to a maximum of 5 times. Participants wears a heart rate belt and a watch that measures physical activity and skin conductance for 34 hours straight. Participants only wears an EEG monitor while sleeping to assess its quality. At the end of the evaluation session, a simulator test mimicking the successive stages of cataract surgery is performed, as well as the performance of saliva tests. Short quality of life assessment questionnaires are completed at the start and end of the day, supplemented by a general questionnaire completed only once during the study.

Statistical analysis will be performed using Stata software (v15, Stata-Corp, College Station, US). Categorical parameters will be described in terms of numbers and frequencies, whereas continuous variables will be expressed as mean and standard deviation or median and [inter-quartile range] according to statistical distribution. All statistical tests will be two-sided and p<0.05 will be considered significant. Graphic representations will be complete presentations of results.

Investigators process multivariate physiological series (HRV, SC, biomarkers) in order to build a stress index. For such multivariate physiological series, investigators first use change point analysis on each univariate series in order to get clusters with constant parameters, then investigators use classification algorithm on the constant parameters obtained in first step in order to obtain different classes corresponding to different levels of stress. Eventually, investigators obtain at each time the level of stress and can compare it to the environmental conditions.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France
        • Recruiting
        • Chu Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Ophthalmologists defined as physicians who completed the ophthalmology DES (Specialized studies diploma), as well as ophthalmology residents defined as a resident registered in the ophthalmology DES working during the inclusion period in the ophthalmology department of the university hospital center of Clermont-Ferrand.
  • Ability to give a written informed consent to participate in research.
  • Affiliation to a social security system.
  • Age between 18 and 65 years old

Exclusion Criteria:

  • Participant refusal to participate
  • Children under the age of 18, pregnant and breastfeeding women, protected adults (individuals under guardianship by court order), adults deprived of their liberty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ophthalmology physicians and residents

Ophthalmology physicians and residents will be followed during 34h, from 8 am to 6 pm the following day,in five different conditions:

  • Control day (no work)
  • Typical working day
  • Working day + one night shift
  • Emergency working day + two consecutive night shifts
  • Night shift.
Evaluate the impact of prolonged work (up to 60 consecutive hours) on the surgical capacities evaluated on a simulator, as well as on stress markers (questionnaires, saliva assays, skin conductance, quality of sleep) compared to a standard day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate variability
Time Frame: During 34 hours in the five different conditions
HRV will be explored in time and frequency domains Abrupt changes in HRV signals will be explored.
During 34 hours in the five different conditions

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in stress levels
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of stress using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in stress levels
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of stress using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
change in fatigue levels
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of fatigue using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in fatigue levels
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of fatigue using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
change in burnout levels
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of burnout using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in burnout levels
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of burnout using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
change in depression levels
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of depression using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in depression levels
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of depression using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
change in anxiety levels
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of anxiety using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in anxiety levels
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of anxiety using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
change in "Job demand control support" levels
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of job demand, job control and support levels using visual analogue scale of 100 mm, from 0 to 100. Higher scores of demand mean a worse level. Higher scores of control and support mean a better level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in "Job demand control support" levels
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of job demand, job control and support levels using visual analogue scale of 100 mm, from 0 to 100. Higher scores of demand mean a worse level. Higher scores of control and support mean a better level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
change in "Effort reward imbalance" levels
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of effort reward imbalance using visual analogue scale of 100 mm, from 0 to 100. Higher scores of mean a better outcome level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in "Effort reward imbalance" levels
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of effort reward imbalance using visual analogue scale of 100 mm, from 0 to 100. Higher scores of mean a better outcome level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
change in work addiction levels
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of work addiction using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in work addiction levels
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of work addiction using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
change in sleep quality
Time Frame: at 8am, beginning of the 34 hours follow-up, in the five different conditions
measure of sleep quality using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 8am, beginning of the 34 hours follow-up, in the five different conditions
change in sleep quality
Time Frame: at 6pm, end of the 34 hours follow-up, in the five different conditions
measure of sleep quality using visual analogue scale of 100 mm, from 0 to 100. Higher scores mean a worse outcome level.
at 6pm, end of the 34 hours follow-up, in the five different conditions
Saliva biomarkers cortisol
Time Frame: baseline of the 34 hours procedure, in the five different conditions
measure on Cortisol
baseline of the 34 hours procedure, in the five different conditions
Saliva biomarkers cortisol
Time Frame: 24hours after the beginning of the procedure, in the five different conditions
measure on Cortisol
24hours after the beginning of the procedure, in the five different conditions
Saliva biomarkers dheas
Time Frame: baseline of the 34 hours procedure, in the five different conditions
measure on dheas
baseline of the 34 hours procedure, in the five different conditions
Saliva biomarkers dheas
Time Frame: 24 hours after the beginning of the procedure, in the five different conditions
measure on dheas
24 hours after the beginning of the procedure, in the five different conditions
Saliva biomarkers lgAs
Time Frame: baseline of the 34 hours procedure, in the five different conditions
measure on lgAs
baseline of the 34 hours procedure, in the five different conditions
Saliva biomarkers lgAs
Time Frame: 24 hours after the beginning of the procedure, in the five different conditions
measure on lgAs
24 hours after the beginning of the procedure, in the five different conditions
Saliva biomarkers Leptine
Time Frame: baseline of the 34 hours procedure, in the five different conditions
measure on Leptine
baseline of the 34 hours procedure, in the five different conditions
Saliva biomarkers Leptine
Time Frame: 24 hours after the beginning of the procedure, in the five different conditions
measure on Leptine
24 hours after the beginning of the procedure, in the five different conditions
Saliva biomarkers Ghrelin
Time Frame: baseline of the 34 hours procedure, in the five different conditions
measure on Ghrelin
baseline of the 34 hours procedure, in the five different conditions
Saliva biomarkers Ghrelin
Time Frame: 24 hours after the beginning of the procedure, in the five different conditions
measure on Ghrelin
24 hours after the beginning of the procedure, in the five different conditions
Declared level of physical activity
Time Frame: once at 8am, at the beginning of the procedure
Physical activity is assessed with one question
once at 8am, at the beginning of the procedure
Level of physical activity
Time Frame: during 34 hours, in the five different conditions
Physical activity is assessed with a 3-Axis accelerometer
during 34 hours, in the five different conditions
Level of sedentary
Time Frame: once at 8am, at the beginning of the procedure
Sedentary is assessed regarding the time spent sitting assessed with one question
once at 8am, at the beginning of the procedure
Food intake
Time Frame: 34 hours recording, in the five different conditions
assessing food intake with ingesta
34 hours recording, in the five different conditions
Sick leave
Time Frame: once at 8am, at the beginning of the procedure
assessing the number of absence days the previous 6 months using a questionnaire
once at 8am, at the beginning of the procedure
Height
Time Frame: once at 8am, at the beginning of the procedure
measure of height in cm using a questionnaire
once at 8am, at the beginning of the procedure
Weight
Time Frame: once at 8am, at the beginning of the procedure
measure of weight in kilograms using a questionnaire
once at 8am, at the beginning of the procedure
Age
Time Frame: once at 8am, at the beginning of the procedure
measure of age in years using a questionnaire
once at 8am, at the beginning of the procedure
Gender
Time Frame: once at 8am, at the beginning of the procedure
measure of gender using a questionnaire
once at 8am, at the beginning of the procedure
Qualification
Time Frame: once at 8am, at the beginning of the procedure
measure of qualification using a questionnaire
once at 8am, at the beginning of the procedure
Personal status
Time Frame: once at 8amat the beginning of the procedure
measure of personal status using a questionnaire
once at 8amat the beginning of the procedure
Lifestyle
Time Frame: once at 8am, at the beginning of the procedure
Assessing factors related to lifestyle as smoking, alcohol and coffee consumption using a questionnaire
once at 8am, at the beginning of the procedure
Skin conductance
Time Frame: during 34 hours , in the five different conditions
measure of the skin conductance using Wrist band electrodes
during 34 hours , in the five different conditions
Sleep quality
Time Frame: measure for about 7 hours the night of the control day (no work)
measure of sleep quality using Sleep profiler
measure for about 7 hours the night of the control day (no work)
Sleep quality
Time Frame: measure for about 7 hours during the night of the typical working day
measure of sleep quality using Sleep profiler
measure for about 7 hours during the night of the typical working day
Surgical performance
Time Frame: Once at 6pm, at the end of the 34 hours follow-up , in the five different conditions
assessing surgical performance using a high-end virtual reality simulator for intraocular surgery training
Once at 6pm, at the end of the 34 hours follow-up , in the five different conditions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 6, 2021

Primary Completion (Anticipated)

July 1, 2025

Study Completion (Anticipated)

July 1, 2025

Study Registration Dates

First Submitted

June 22, 2021

First Submitted That Met QC Criteria

July 12, 2021

First Posted (Actual)

July 13, 2021

Study Record Updates

Last Update Posted (Actual)

June 6, 2022

Last Update Submitted That Met QC Criteria

June 3, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • RBHP 2020 DUTHEIL 2
  • 2020-A03231-38 (Other Identifier: 2020-A03231-38)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Impact of prolonged work

3
Subscribe